Interesting angle. I did note the drug company, but didn't realize they lacked clout.
Seemed like a long time (6 mos. since approval?) for formulary uptake by large ins. companies. And strange that smaller ins. companies (not sure which ins. companies) would add to formulary first.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.